JPS58189112A - Production of material containing physiologically active substance - Google Patents

Production of material containing physiologically active substance

Info

Publication number
JPS58189112A
JPS58189112A JP57073570A JP7357082A JPS58189112A JP S58189112 A JPS58189112 A JP S58189112A JP 57073570 A JP57073570 A JP 57073570A JP 7357082 A JP7357082 A JP 7357082A JP S58189112 A JPS58189112 A JP S58189112A
Authority
JP
Japan
Prior art keywords
physiologically active
active substance
substance
continuously
transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57073570A
Other languages
Japanese (ja)
Other versions
JPH0530806B2 (en
Inventor
Tetsuo Horiuchi
堀内 哲夫
Yusuke Ito
祐輔 伊藤
Akira Tateishi
立石 皓
Yoshio Miki
三木 祥男
Isao So
宗 伊佐雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP57073570A priority Critical patent/JPS58189112A/en
Publication of JPS58189112A publication Critical patent/JPS58189112A/en
Publication of JPH0530806B2 publication Critical patent/JPH0530806B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:A tightly sealed transferring machine that can continuously send the substance as the content is always made to renew its surfaces, is provided with a temperature-controling mechanism all over the transferring zone as well as a plurality of feed inlets is used to produce a material containing a physiologically active substance continuously without loss of the active substance. CONSTITUTION:A tightly sealed transferring machine that can continuously send the substance as the content is always made to renew its surface and is provided with temperature controlling mechanisms 9-15 all over the transferring zone and a plurality of feed inlets 2-6, e.g., a single-screw or double-screw extruder is used to feed a carrier containing a thermoplastic high molecular material capable of forming films and keeping their form and physiologically active substances to these inlets continuously. They are mixed in the machine under the tightly sealed conditions and the heating of the machine is controlled by means of the mechanisms all over the transferring zone to prevent the loss caused by evaporation and decomposition of the active substance, thus producing a material containing physiologically active substance alone or a combination thereof with a backing material 21 continuously with advantage.

Description

【発明の詳細な説明】 牡又は分解(こLる損失をなくしまた生理活性物質含有
物(IJ.−F4勿電含有柳という)の製法及び核製法
にjつでfi4らる吻質含有物金嬢独で又は裏打ち材料
と阻み合せて、連続的に生4活性4B質含有シート又は
フィルムを製造するtr規な方法に関するものである。
[Detailed Description of the Invention] A method for producing a bioactive substance-containing material (referred to as IJ.-F4 Makuden-containing Yanagi) and a nuclear production method that eliminates this loss. The present invention relates to a conventional method for continuously producing sheets or films containing bioactive 4B substances either alone or in combination with a backing material.

本発明は、物帷倉有吻製造時の熱容緻を少なくすること
に工・ノて生理活性物質の分解をなくすと共に、密閉系
移送器内で均一に混合を行うことに工つ゛C生4r占性
物質の暉敗をなりシ、シかも連続的に#繊含何物又は七
のθΩ工品を製造する方法を提供するものであるー。
The present invention utilizes techniques to reduce the thermal densities during the production of the material, thereby eliminating the decomposition of physiologically active substances, and also to ensure uniform mixing within the closed system transfer device. The purpose of the present invention is to provide a method for continuously manufacturing #fiber-containing materials or #7 θΩ products by destroying 4R-occupied substances.

1投に、生4活性物質と該物質を担持する担体とから樽
!戊される物質含有物は、fg解、混合1重合、乳化な
どの手法による担体加エエ慢と、これに生理活性物′−
を配合する工爛とを唖て作らnる@記担体/JOエエ描
には、攪拌羽根やホモミキ丈−ヲ有する釜か、ミキシン
グロール、バンパリーミキザー、加圧ニーダ−、ニーダ
−ルーダ−などの混合装置が一般的に1史用される。
A barrel containing 4 raw active substances and a carrier that carries the substances in one bowl! The substance content to be extracted is obtained by adding a carrier by methods such as fg decomposition, mixing and polymerization, and emulsification, and adding a physiologically active substance to this.
The carrier made by the process of blending the mixture includes a stirring blade, a pot with a homogeneous mixer, a mixing roll, a bumper mixer, a pressure kneader, a kneader-ruder, etc. Mixing equipment is commonly used.

しかしC1こCらの釜f混合装置を用いてなる加f、上
程は、開放系のバッチ万代であったり、加工時熱がυl
えらnたりするために、大部分が比較的saが=<、s
散性でめることが多い生4f′8性吻電を配置するとき
は、r4Wi又は熱分解にLる損失をfめ艶色んで配合
する必要があるために不経済であると決(こ、ゲ定且つ
均一なりE質倉何物を提供することは1雌であるという
χ点がある。
However, the addition process using the kettle mixer of C1 and C1 is an open batch process, and the heat during processing is υl.
Most of them are relatively sa =<, s
When arranging raw 4F'8 anastoelectrics, which are often dissipated, it is decided that it is uneconomical because it is necessary to mix in a glossy color to reduce losses due to r4Wi or thermal decomposition. There is a χ point that it is one female to provide an E-quality warehouse product that is consistent and uniform.

さしくこLA己0す法でυミニさrた物質含有物を、こ
れ単独で、或いは裏打ち材料と組み合せて、シート父は
フィルム化するときにVユ、前記物置含有物t−溶媒を
用いて希釈して離型ライナートにキャスティングするか
或いは裏打ち材料面に塗布含浸するかし2C加熱乾燥す
るか、又は前記物置8有物f T タイ押出機やホット
メルトアプリケータ一番こ゛(溶4111押出億工する
か或いはカレンダーロールで圧延するかり、r、’/−
)父はフィルム化するために、こnらの加熱−自にLり
C1生理活性物質の情夫がさらに助陵されるものである
When the material containing material, which has been miniaturized by the Sashikuko LA self-zero method, is used alone or in combination with a backing material, the sheet material is made into a film using the above-mentioned material containing material t-solvent. Either dilute it and cast it on a mold release liner, or apply it to the backing material surface and then heat and dry it, or use a tie extruder or hot melt applicator as described above. Either roll it or roll it with a calendar roll, r,'/-
) In order to make the film into a film, the lover of the L C1 physiologically active substance is further aided by these heating processes.

向えば、丈すチル涜グリコール、e−メントール、  
d/−カンファーの如き揮#に、性薬物を上薬とするグ
ラスターは、公mlの肴不成分をバンパリーミキリ゛、
−で混ビしてから薬物を配合して物繊含有物を作り、こ
nを小鐵布の如き裏打ち材料面ICカレンダーロー/L
で延展塗布し−C作らnるために、物[ざ自゛吻及び咄
I!th″″′−布時の加熱にLつC薬物の連数又は分
解に↓る変質が起生じ、ゲ定はつ均一 1プラスターが
潜らCにぐいという問題があり、ま九薬#瞳のみを4え
る場合はかかる損失又は分解による′&−などに↓る損
失を見込んで4(勿を踵i合しCお・かなげ/Lばなら
ないという唖済上の問題があ5ものCろ口、 一= /j 、ステし・ンーイソプレン(又はプタジエ
/)−ステし・/ブロック残置合体の如右熱1=T @
注エノストンーと油成分とを加熱fg解し、これに乳化
削、水位び4物を1.1≦加してspy/○型工ンルジ
日/糸の物111必を作る方法も櫨々提案さく’LCい
る。し力・して、り・、O≧6方法においCも、水の沸
薇頃界と溶解極度と−i)関係から、一般に90℃前後
に昇温ざ/Lるが、はり薬物の連数などによる損失は免
社ないもので2わる。
On the other hand, chill glycol, e-menthol,
d/-Glaster, which uses a sex drug as a stimulant like camphor, absorbs the unflavored ingredients of public ml,
After mixing with - and then blending the drug to make a fiber-containing material, this is lined with a backing material such as small iron cloth and IC calender row/L.
Spread the material and apply it to make the material. th''''' - Due to the heating during the cloth, deterioration occurs in the series or decomposition of the L C drug, and the gelation is uniform. When calculating 4, take into account such losses or losses due to decomposition such as '&-' and Mouth, 1 = /j, Stish-N-Isoprene (or Petazier/) - Stish-/Block remaining combination like right heat 1 = T @
Note: He also proposes a method to make a spy/○ type machine/thread item by heating and dissolving the enostone and oil component, emulsifying it, and adding 1.1 or less of the following four ingredients. 'LC is here. In the O≧6 method, the temperature is generally raised to around 90°C due to the relationship between the boiling point of water and the solubility limit. Losses due to numbers, etc. are 2 times less if the company is exempt.

従つ°C本儀明の第一の目的は、生理活性切電のi4赦
又yi汁袢による損失をなくした物置含有物の製法をI
、ll!共fることにある。
Accordingly, the first purpose of this book is to develop a method for producing a storage product that eliminates the loss caused by physiologically active cutting.
,ll! It's about the same thing.

本発明θ第二1の目的は、物質き何物を連続的に作る製
法を提供することにろるっ 不発・夕Jの第三の1的は、**含有物単独又は物′繊
含自物と裏打し材料とを組み台♂”Cな6吻藏含Hシー
 ト又はノイルムを連続的に製造する方法を提供するも
のである。
The second and first object of the present invention is to provide a manufacturing method for continuously producing substances. The present invention provides a method for continuously manufacturing a 6-prong-containing H sheet or noilm by assembling the original material and a backing material.

かかる本発明の目的は、内容物を表面(#シつつ連続的
に移送可能で且つ上記移送過橿の全域に■つm度例調機
導と置数1園の原料供給口とを1繍えた密閉系移送4を
使用し、この移送器内へ皮嘆形成能及び保型を有する熱
1lIr塑性高分子材料を含む担体と生理活性物質とを
F記供給口η為ら連続供給し、E記移送過僅の全域(こ
亘って所定の温度に卯熱例−しつつ上記担体と物質とを
密閉状態で均=(C1汗し゛C連続的に移送4から取り
出すこと1て工つC4成さルるっ 本発明を工す成体的に説明すると、内d物を表]釦V!
祈しつつ移送「1丁−で、4通過程の全域に城ってIj
1度@−がIIJ吐を密閉系移送器内に、目的とするI
Ik終吻品番C応じて現体及び生理活性物シを順次fl
il々の頑、H供給口から連続的に供給し、予め設定さ
nた移送4内のスフIJ、−にて内容物を密閉系で均一
に混合し9つ移送させc#kJ値含有物全作る方法を提
供するものであるっ 本発明の一法に工れば、*實N何物は密閉糸で製造ざル
ること、及び内容物は表面更新しつつ均一に混合さrる
ために個々に受ける熱害11(@度×時間の積)が少な
いことなどに起因し゛〔、生理活性物質の揮散や分解に
よる変質が製造中+C殆んどないという特徴を有する。
The object of the present invention is to be able to continuously transfer the contents while transferring the contents to the surface, and to provide one feeder and one raw material supply port in the entire area of the transfer tube. Using the closed system transfer device 4 prepared above, a carrier containing a thermoplastic polymeric material having skin-forming ability and shape retention and a physiologically active substance are continuously fed into the transfer device from the supply port F, and The carrier and substance are homogenized in a sealed state while heating the entire area of the transferred area (for example, to a predetermined temperature). To explain the present invention in detail, it is possible to display the internal objects] Button V!
Transfer while praying, ``With one gun, I'm going to cover the entire area of the 4-way process.''
Once the IIJ is discharged into the closed system transfer device,
According to the Ik terminal proboscis product number C, the actual and physiologically active substances are sequentially fl
Continuously supply from the H supply port, mix the contents uniformly in a closed system in the preset transfer 4, and transfer the contents containing c#kJ value. By applying one method of the present invention, the present invention provides a method for making all the products.In fact, nothing can be manufactured with closed threads, and the contents can be mixed uniformly while renewing the surface. This is due to the fact that the heat damage 11 (@ product of degree x time) that is individually suffered during production is small, and there is almost no change in quality due to volatilization or decomposition of physiologically active substances during production.

さらKI&合工橿が、部分的には少緻である内容物をそ
の部分のスクリューで処理するものであるから、少ない
動力ですみ、装置を小型化できるとめう特敞を有する、
IJ、下図面を用いて本発明の製法の一列を示す。
Because Saraki & Gouko-kashi partially processes the contents that are small in size using the screw in that part, it has the special feature of requiring less power and allowing the equipment to be made more compact.
IJ, one line of the manufacturing method of the present invention is shown using the drawings below.

図面は本発明に用いる密閉系移送器の一例である一軸ス
クリーー押出機の断面構造を示したもので、図面におい
て、1は押出機外筒を構成するバレル1で、Uの一端V
こ皮嘆形成及び保型能を有する熱り塑性高分子材料を含
む担体又は生理活性物質の一部を供給する主供給口2が
設けらル、他端には押出ダイス16が設けられ°〔いる
っ3s 4s 5及び6は供給口はであり、図示する如
く、主供給口2を基準に1−で、3.4.57iび6の
供給口は略等間隔で設けら扛ていてもよいが、列えば供
給初期に全部を混汗する一合((は主供給口2の近辺に
集中の組み合せを適宜選択することに工り町9日で6る
The drawing shows the cross-sectional structure of a single-screw extruder, which is an example of a closed system transfer device used in the present invention.
A main supply port 2 is provided for supplying a carrier containing a thermoplastic polymer material having skin formation and shape retention ability or a portion of a physiologically active substance, and an extrusion die 16 is provided at the other end. 3s 4s 5 and 6 have supply ports, and as shown in the figure, the main supply port 2 is 1-, and the supply ports 3.4.57i and 6 are provided at approximately equal intervals. However, if it is lined up, it will be necessary to select an appropriate combination of concentration in the vicinity of the main supply port 2, which will mix everything in the early stage of supply.

また#記ダイス16は、押出機から連続しC物質含有物
の供給を受けると共に、さらに連続し〔物質含有物をこ
れ単独で又は夷打ち材料21と組み合せて、物質含有シ
ート又はフィルム状1’CFる場合に用いらnるもので
あり、かかるダイス16を取り外しC1バレル1の取り
出し口Aから物質含有物の木を得ることができる。
The die 16 marked with # is continuously supplied with the substance-containing material C from the extruder, and is further continuously supplied with the substance-containing material alone or in combination with the punching material 21 to form a material-containing sheet or film 1'. The die 16 is removed and the substance-containing wood can be obtained from the outlet A of the C1 barrel 1.

バレル1の内部には、回転する軸心7にIII数個のス
クリュー8a、8b、 8c、 8a及び8eが装着さ
れ〔いるっこ!tらのスクリー−8a、−−−は、担体
及び生理活性物質の性状或いは(頃Kx、っc1 形状
、径峻び6回が、均一1合にi&嶺条1′l:とケるL
うに組み合されるっ と・リスクリー−8a、−−−+ζLって、主供給口2
〜6から一次共諭された′fkJ質含有物用何物を軸心
7の回転で、移送、滞留及び逆送させて混合し、前進さ
せ6つスクリュー8’%    I:バレル1の内面と
の間隔は、混和性をLくするために・産を設計さnるが
、一般には0.5〜2閣とされる。
Inside the barrel 1, several screws 8a, 8b, 8c, 8a and 8e are attached to the rotating shaft center 7. Scree-8a,--- of T et al.
When combined, Risky-8a, ---+ζL is the main supply port 2.
~ 6, the ``fkJ quality inclusions'' are transferred, retained, and reversed by the rotation of the axis 7, mixed, and advanced by 6 screws 8'% I: Inside of barrel 1 and The spacing is designed to increase miscibility, but it is generally set to 0.5 to 2 spacings.

9.10%11.12.13.14及び15は、バレル
1の全各部及び前記ダイス16Keけらn走加熱制#器
で、各部Kjって適当な!lF1.に制御できる構成と
され゛〔いるが、全長を均等に加熱−JtlilするW
II成とすることは勿論可能である。
9. 10% 11. 12. 13. 14 and 15 are all parts of the barrel 1 and the die 16Ke, n running heat limiter, and each part Kj is appropriate! lF1. It is said that the structure can control the heating evenly over the entire length.
Of course, it is possible to make it a II configuration.

なお図中18.19.20.21及び22は、バレル1
の取り出り口AK@り付けたダイス16の押出口17か
ら押し出された物質含有物を、裏打ち材料21と(み合
せr物質含有シート又はテープBとする丸めのもので、
18はパックロール、19は貼り合せロール、20はガ
イドロール、22は裏打ち材料21の表面に構成され九
m′jit体−Cの表面を保接する@噛フィルム父はε
の煩似吻品であるっ Iu hのように構成さJtrl、n、6#出礪内に、
例えば、まず主供給口2から任意の担体を連続的に供給
すると共に、 3.4、s及び6の供給口から生理活性
物質を始めとする配合物を順次連続的に供給し、スクリ
ーーga、−−一の回転に工っC内容物の表面を更新し
つつ移送して均一に混合して、機内の密閉系で均一な生
理活性物jltA合物を作り、取り・bし白Aから生理
活性物1倉有(勿を取り出すか、或(^lよさら1こ衣
り出し口Aにダイス16を喉り付けてシートエはフィル
ム状に成形し、プラスチックフィルムV、はシート、不
峨布、・哉布、発泡フィルム又はシートの如き幌打ち材
料21とラミネートする本のでろる。
In addition, 18, 19, 20, 21 and 22 in the figure are barrel 1
The substance-containing material extruded from the extrusion port 17 of the die 16 attached to the outlet AK@ is combined with the backing material 21 (a round substance-containing sheet or tape B,
18 is a pack roll, 19 is a bonding roll, 20 is a guide roll, and 22 is a film formed on the surface of the backing material 21 and attached to the surface of the 9m'jit body-C.
It is a similar proboscis product of Jtrl, n, 6#, which is configured like Iu h,
For example, first, an arbitrary carrier is continuously supplied from the main supply port 2, and a formulation including a physiologically active substance is sequentially and continuously supplied from the supply ports 3.4, s and 6, --Transfer and mix uniformly while renewing the surface of the contents in the first rotation, create a homogeneous physiologically active substance jltA compound in a closed system inside the machine, remove and remove the physiologically active substance jltA from white A. Take out 1 cup of active material (or (^l) Put die 16 into the opening A of the active material and form the sheet into a film, and the plastic film V is a sheet or a non-woven fabric. The book can be laminated with a covering material 21 such as cloth, foamed film or sheet.

また、E記の図例では、−紬スクリーー押出機を用いC
いるが、二軸スクリーー押出磯・を用いて4F記と四欅
の操乍で吻−1で混合できることが理1’illざイL
るでめ・5つ〕 一袖又・ま二軸櫨のスフ17 W−押”b*に紛いCは
、前述しtダ日く、スクリーーとバノル内函との間隔は
、好ましく1fiO65〜21′j111pi度に設計
さ扛るが、Uの速tt =y配、即ち(円司彰(→/回
横数×スクリ二−外径/スクリーーとバレルとのf”j
[)は、一般に1000/min以上に設計さnCいる
のが好まし7いものである。
In addition, in the example shown in E, using a Tsumugi Scree extruder, C
However, it is logical that it can be mixed in the proboscis-1 by using a twin-screw extrusion machine and operating the 4F mark and the four keys.
[Rudeme / 5 pieces] One-sleeve mata / double-shafted oak sufu 17 W-press"b* (C) is as described above, the distance between the screen and the Banol inner box is preferably 1fiO65-21 Although it is designed to have 111 pi degrees, the speed of U = y distribution, that is, (Enji Akira (→/Number of laterals x screenie outer diameter/f''j between screen and barrel)
[) is generally preferably designed to have a nC of 1000/min or more.

また本発明に用いる移送器は、密閉系で、内谷物の表面
をスクリューとバレルの作用により常に更新し′C,連
続的に移送するものであり、しかも移送4椙の全域に亘
つCa度制御機構と複数個の供給口を噌えたものであれ
ば、上記の−又は二輪型スクリュー押出機に噴定されず
使用できる。
In addition, the transfer device used in the present invention is a closed system, and the surface of the inner grain is constantly updated by the action of the screw and barrel, and the Ca content is continuously transferred over the entire area during the 4 hours of transfer. As long as it has a control mechanism and a plurality of supply ports, it can be used without being jetted into the above-mentioned two-wheel or two-wheel screw extruder.

E記製法において、移送器にて目的とする生理活性物質
含有物を得る九めKは、当然のことながら、供給口から
供給される担体及び生理活性物質の性状及び供給位置を
選択すると共’rc bバレル各部の温度を制御するこ
とによって、内容物のバレル内での粘度を制御すること
は重要なことであり、この粘度制御が不充分であると内
容物の逆流nや、不均一な物質含有物しか得られないと
いう不都合があるっ 安定移送に好ましい粘度は、移送器の4屓、大きさ、バ
レル面とスクリ鳳−との間隙、担体の種類及び粘度、内
容物の移送速度、目的とする生理活性物質混合物の性状
などに工っでも異なるが、一般には100〜数万ポイズ
の範囲である。
In the manufacturing method described in E, the key to obtaining the desired physiologically active substance-containing product using the transfer device is, of course, to select the properties and supply position of the carrier and physiologically active substance supplied from the supply port. It is important to control the viscosity of the contents inside the barrel by controlling the temperature of each part of the rc barrel, and if this viscosity control is insufficient, the contents may backflow or become uneven. There is the disadvantage that only substances containing substances can be obtained.The preferred viscosity for stable transfer depends on the width and size of the transfer device, the gap between the barrel surface and the screw, the type and viscosity of the carrier, the transfer speed of the contents, Although it varies depending on the properties of the target physiologically active substance mixture, it is generally in the range of 100 to several tens of thousands of poise.

次に本発明を実施するに当つ′C使用される担体及び生
理活性物質について説明する。
Next, carriers and physiologically active substances used in carrying out the present invention will be explained.

担体は生理活性*質含何物の母体成分であって、且つ生
J!活性#II質を溶解又は均−分散状暢で保持する担
持成分であ企。
The carrier is a parent component of the physiologically active substance and contains raw J! It is intended to be a carrier component that maintains active substance #II in a dissolved or uniformly dispersed state.

物質含有物の厳終形状は、前述の如く、物質含有物単独
又は裏打ち材料との組み合せでシート又はフィルム状と
される以外に、物質含有物を所定形状K例えば動植物の
形に象った成形品とされるものであり、従り゛C1担体
の主ノ項@fcる熱可塑性高分子材料には、少なくとも
皮′#!形成能と保型能を有する高分子材料の物質が選
択されるものである。
As mentioned above, the final shape of the material-containing material may be formed into a sheet or film by using the material-containing material alone or in combination with a backing material, or by molding the material-containing material into a predetermined shape K, for example, in the shape of an animal or plant. Therefore, the thermoplastic polymeric material that is the main component of the C1 carrier contains at least a skin. A polymer material having forming ability and shape retention ability is selected.

熱可塑性高分子材料としては、スチレン−インプレース
チレンブロック共重合体、スチレン−ブタジェン−スチ
レンブロック共重合体、トランスイノプレン、エチレン
−酢酸ビニル共重合体などの熱rITffi性エフスト
マーが好適に使用されるが、εの咄エチレンーアクリル
0#重合体七の他のアクリル共重合体、ポリエチレン、
ポリプロピレンなどのなどの熱可塑性高分子材料も使用
できる。
As the thermoplastic polymer material, thermoplastic polymers such as styrene-in-place styrene block copolymer, styrene-butadiene-styrene block copolymer, trans-inoprene, and ethylene-vinyl acetate copolymer are preferably used. However, other acrylic copolymers, polyethylene,
Thermoplastic polymeric materials such as polypropylene can also be used.

これらの高分子材料は、粉末、ベレット或いは水分散系
などの任意の形で筐用される。好ましい前記エラストマ
ーは、5Ky/d bJ上の引張強さくムITMD41
2)を有するものであって、かかる引張強さは物質含有
量鵬独でフィルム又はシート状としたときに不必要に破
断することがないうえから好ましいものである。
These polymeric materials can be packaged in any form such as powder, pellets, or water dispersion. The preferred elastomer has a tensile strength comb ITMD41 of over 5Ky/d bJ.
2), and such a tensile strength is preferable since it will not unnecessarily break when formed into a film or sheet depending on the material content.

E記熱可塑性高分子材料と共に必要に応じて弔いらnる
担体成分としては、常温でIIA’1状である粘着付与
性嘴詣、常温で液又は半固形状である婚加物質、吠いは
公知の配合剤などがある。
Carrier components that may be used as necessary together with the thermoplastic polymer material listed in E include a tackifier that is in the form of IIA'1 at room temperature, a tackifying substance that is in a liquid or semi-solid state at room temperature, and There are known compounding agents.

常温で固形状である粘着付体性!R脂としては、ガムロ
ジン、ウッドロジン、ダンマルの如き天然樹脂、重合ロ
ジン、部分水添ロジン、グリセリンエステルロジン、ペ
ンタエリスットエステルロジンの如き変性ロジン及びe
nらの誘導体、ポリテルペン系樹脂、キシレン系橋上、
石油系樹脂、スチレン果樹り旨、クマロンインデン系樹
脂、脂還式飽和炭化水木系S脂などが挙げられる。
Adhesive material that is solid at room temperature! R fats include natural resins such as gum rosin, wood rosin, and dammar, modified rosins such as polymerized rosin, partially hydrogenated rosin, glycerin ester rosin, pentaerythate ester rosin, and e.
derivatives of n et al., polyterpene resins, xylene bridges,
Examples include petroleum resins, styrene fruit resins, coumaron indene resins, and fat-reduced saturated hydrocarbon water-wood S resins.

常儀で液又は半固形状である添加物置としては、ロジン
メチルエステル、水添ロジンメチルエステル、ロジント
リエチレングリコールエステル、水添ロジントリエチレ
ングリコールエステル、ロジンジエチレンクリコールの
如きロジン$樹脂、軟化薇が30℃以下のキ/レン系m
詣、ポリテルペン系4す旨tどの液状#9旨、ジブチル
フタレート、ジオクチルフタレートの如き低分子tII
I塑萌、マシン油、シリンダー油、トランス油、ロジン
油、スヒ“7ドlLmのQロキ1IlIIfJ% eの
@f1.@パラフィン、プロヒスオイシ、植物油、ロウ
類、低分子−着ボリイゾプチレン、低分子曖ポリエチレ
ン、ボリグテン1.夜状ポリブタジェンなどが―げらn
る。
Additives, usually in liquid or semi-solid form, include rosin resins such as rosin methyl ester, hydrogenated rosin methyl ester, rosin triethylene glycol ester, hydrogenated rosin triethylene glycol ester, rosin diethylene glycol, softening Ki/ren type m with rose below 30℃
Polyterpene-based liquid #9, low molecular weight tII such as dibutyl phthalate and dioctyl phthalate
I plastic moe, machine oil, cylinder oil, transformer oil, rosin oil, Suhi' 7 dollar Lm Q loki 1 Il I If J% e @f1. @ Paraffin, prohyde oil, vegetable oil, waxes, low molecular weight polyisobutylene, low molecular weight Polyethylene, borigtene 1. Nocturnal polybutadiene, etc.
Ru.

εの他の配合剤としては、糸を一竜ジ・ン化する場合の
界面活性剤としC1ポリエチレングリコールオレイルニ
ーデル、ポリエチレングリコール、ノニルフェニルエー
テル、ポリエチレングリコールドデシルフェニルエーテ
ル、ゾルビタンモノラウレートなどが、噌緻及び原型を
目的とする充填剤とし−csk酸カルシウム、クレー、
メルク、チタン白、シリカなどが、かの他着色剤、安定
剤、老化防止剤などが用いらnる。
Other compounding agents for ε include C1 polyethylene glycol oleyl needle, polyethylene glycol, nonylphenyl ether, polyethylene glycol decylphenyl ether, sorbitan monolaurate, etc. as surfactants when converting yarn into Ichiryu di-N. However, as a filler for the purpose of compaction and prototype - calcium chloride, clay,
Merck, titanium white, silica, etc. are used, as well as colorants, stabilizers, anti-aging agents, etc.

これらの担体は、目的とする最終物品たる生理活性物質
含有物の性状によって適宜選択されるものであって、該
物質体が感圧接着性を有するLうに設計する場合は、前
記高分子材料と常温で固形状である粘着付与性樹脂及び
/又は添加物質とを、1:0゜1〜10(重量比)の割
合で配合することが好ましいものであるっまたWlO型
エマルジ璽ン幕感圧接着性の物質体を設計する場合には
、前記高分子材料と、添加物質中の油類と、前記界面活
性剤と、水とを、高分子材料(好ましくはエラストマー
)100重喰部に対して夫々5〜301i一部及び1〜
201量部の割合で配合すると共に1水はW10型エマ
ルジ冒ン中の水粒子の割合が80重置%以下となるよう
に配合さnる。
These carriers are appropriately selected depending on the properties of the desired final product containing a physiologically active substance, and when the material is designed to have pressure-sensitive adhesive properties, the carrier is compatible with the polymeric material. It is preferable to mix the tackifying resin and/or the additive substance, which are solid at room temperature, in a ratio of 1:0°1 to 10 (weight ratio). When designing an adhesive substance, the polymer material, the oil in the additive substance, the surfactant, and water are added to 100 parts by weight of the polymer material (preferably elastomer). 5~301i part and 1~
The amount of water is 201 parts by weight, and the water is added so that the proportion of water particles in the W10 emulsion is 80% or less.

蚊W / O型エマルジ■ン系感圧接着性物質体は、前
記移送器又はダイスからJ&抄出して、室弧域まで冷却
することによりゲル化させると、含水ゲル中に生理活性
物質を担持してなる生理活性物質含有物が得らnる、 前記担体に担持さn1生珊学的に櫨々の機能をQ1針る
生1f8性物質としCは、大別すると生物学的IC杆容
さルる物質とa理学的に許ン≠さnる物質とに別けらn
る。
Mosquito W/O type emulsion pressure-sensitive adhesive material is extracted from the transfer device or die and cooled to a room arc region to gel, and a physiologically active substance is supported in the hydrous gel. A physiologically active substance-containing substance is obtained, which is a biologically active substance supported on the carrier that has a biologically active function of Q1, and C is a biological IC rod. There is a distinction between substances that are physically acceptable and substances that are physically acceptable.
Ru.

生物学的に許与さnる生理活性物質とは、密閉系或いは
開放系を問わず、所定の使用環境下に物質含有物を配役
ときに、物質含有物の表面に滲出したり、空気中に憚散
し、tりし“で1 目的とする幼果を4F3憚するもの
であって、例えば殺虫剤、殺菌剤に除革剤、植物生長促
進剤、m物生長抑制剤、栄養剤、鴫薬、植物ホルモン、
動物ホルモン、動物フェロモン、防錆剤、防黴剤、香料
などが嘗げられる。
Biologically acceptable physiologically active substances are substances that ooze out onto the surface of a substance-containing substance or are released into the air when the substance-containing substance is placed in a specified usage environment, whether in a closed system or an open system. It is a substance that destroys the target young fruit by 4F3, such as insecticides, fungicides, leather removers, plant growth promoters, growth inhibitors, nutrients, etc. Dry medicine, plant hormones,
Animal hormones, animal pheromones, rust inhibitors, anti-mold agents, fragrances, etc. can be tasted.

を丸薬理学的に許浮される生理活性物質とけ、管理fV
′Lfit K間部的に或すは管理位置から遠<fll
jn九位置に、組織的に薬理効果させる有機又は無機系
薬理化合物であって、例えば睡眠剤、鎮静剤、神〆蔓安
定剤、痙り抑制剤、筋肉弛緩剤、アンチパーキンンン剤
、解熱剤、炎症治療剤、間部麻酔剤、鎮花剤、債瘍治僚
剤、血管拡張剤、ホルモン剤、心蔵血管剤、利尿剤、交
感神唖安定剤、低血糖症治療剤、a[薬、消炎鎮痛剤な
どが、−げら6る。
The pill is pharmacologically released to dissolve physiologically active substances, and the management fV
’Lfit K locally or far from the management position
An organic or inorganic pharmacological compound that exerts a systematic pharmacological effect at the jn9 position, such as a sleeping agent, a sedative, a tranquilizer, a spasticity suppressant, a muscle relaxant, an anti-inflammatory agent, an antipyretic agent, Inflammation treatment agents, intervening anesthetics, antidepressants, tumor healing agents, vasodilators, hormonal agents, cardiovascular agents, diuretics, sympathomimetic stabilizers, hypoglycemia treatment agents, a [drugs, Anti-inflammatory analgesics, etc. are used.

しかして本発明の製法は、前述の如く、制御された@度
条件で短時間で、しかも密閉状すで生理活性物に含有物
を製造することに工っC1主場活性物質の揮散又は分解
による損失を著しく低下させることができるものである
から、サリチル酸エステル、e−メントール、dIl!
l−カンファーの々口き一般に製造工程中の損失が大き
いとさnている消炎鎮痛剤を生理活性物質としC用いて
物gI含有物を咋るとき(こ、殊に有用であることが理
解されるで1bろう1、 +角内の製法は以Fの実−例に工り桟体的に説明さnる
が2本発明は以下の夷櫓例に晦定さnるものではな(,
1つ以下の実lIA同において、丈中部及び%とちるの
は′!!r1″Lも重駿嚇位を意味するものとする。
Therefore, as mentioned above, the production method of the present invention is capable of producing substances contained in physiologically active substances in a short time under controlled temperature conditions and in a sealed state. Salicylic acid ester, e-menthol, dIl! can significantly reduce the loss.
It is understood that this is particularly useful when using anti-inflammatory analgesics as a physiologically active substance and sipping l-camphor, which generally causes large losses during the manufacturing process. The manufacturing method of the 1b wax 1, + corner will be explained below in terms of the actual example of the construction frame, but 2 the present invention is not limited to the following example of the turret. ,
In less than one fruit lIA the same, the middle part of the length and % are '! ! It is assumed that r1″L also means the jusun menacing position.

実施料1 スクlJ、、外径40關、バレル醍さ2160鴎、バレ
ルとスクリー−との間隙1゜001!IIIで、添付間
開における1〜Vl■]−ンの@建を全°C70℃に制
御すると央にs 62807m i nの;虫度勾配に
設定した一輪スクリーー押出礪を用い、主供給口2から
、酢酸ヒニル含ut呪33%のエチレン−酢酸ビニル共
電合本ペレット’4r: 3 Kg/ m i nの割
合で連続的に供給し、さらに供給口6からし七ン系香料
(レモ7673−858/’A )を0.6Kl/mi
nの割合で連続的に供給し〔均−tで混合し、取り出し
口Aからレモン*香料含有混和物を侍たつ 取り出し後直(C混合物を厚さZoo)tmのポリエス
テルフィルムの表面に1゜5關厚で塗設し、芳香シート
を作成したつ 核シートの単位体積当りの香料量(測定#L)は16.
42%で、埋鍮配合着の16゜67%とは殆んど磨がな
いものであった。
Pricing fee 1 SklJ, outer diameter 40mm, barrel strength 2160mm, gap between barrel and scree 1°001! In III, when the total temperature of 1 to Vl]-n in the attached gap is controlled at 70°C, the main supply port 2 is Ethylene-vinyl acetate co-electric composite pellets '4r containing 33% vinyl acetate were continuously supplied from the feed port 6 at a rate of 3 Kg/min. -858/'A) at 0.6Kl/mi
Continuously supply the mixture at a ratio of n [uniformly - t], and immediately after taking out the lemon*flavor-containing mixture from the take-out port A (the mixture C was mixed to a thickness of Zoo) 1° on the surface of a polyester film of tm. The amount of fragrance per unit volume of the core sheet (measured #L) was 16.
42%, and there was almost no polishing compared to the 16°67% of the embedded brass mixture.

ジー4施七ンリ2 スクリュー外径5〇−膳、バレル擾さ2160’ in
a+。
Gee 4 Shichirinri 2 Screw outer diameter 5〇-zen, barrel width 2160' in
a+.

バレルとスクリー−との間隙1゜Oamで、添付図面に
おける1〜[=170℃、I= 140”C1ff−1
204c、V−100℃、Vl〜W=90℃文びff〜
■=80℃に夫々@度制御すると共に、62800/w
inの速度勾配に設定し九−軸スクリーー押出機を用い
、供給口2から、スチレン含有l130%、モ均分子1
115万のスチレン−ブタジェン−スチレンブロック共
重合体を16679/rn1nの割合で連続的に供給し
、1′J、下共給口3から乎均分子量1260のポリイ
ソブチンを167ノ/m i nと粘度350セイボル
ト抄の流動パラフィンを333j’/winとの割合で
、供給口4から軟化点115℃のポリテルペン系41を
脂t 1 a a 3?/m1n1供給口6からサリチ
ル酸モノグリコール:l−メントール=1:1の混合薬
物33497m1nの割合いで連続的に夫々供給し゛〔
均一に混合し、プラスター用膏体を製造した。
With a gap of 1° Oam between the barrel and the scree, 1 to [=170°C, I=140”C1ff-1 in the attached drawing
204c, V-100℃, Vl ~ W = 90℃ text ff ~
■=80℃ and 62800/w
Using a nine-screw extruder with a speed gradient of
1,150,000 styrene-butadiene-styrene block copolymer was continuously fed at a ratio of 16679/rn1n, and polyisobutyne with an average molecular weight of 1260 was fed from the lower common feed port 3 at 1'J with a viscosity of 167 min/min. 350 Saybold paper liquid paraffin at a ratio of 333j'/win, polyterpene type 41 with a softening point of 115°C is fed from the supply port 4 to fat t 1 a a 3? /m1n1 From the supply port 6, a mixed drug of monoglycol salicylate: l-menthol = 1:1 was continuously supplied at a ratio of 33497ml.
The mixture was mixed uniformly to produce a plaster body.

この膏体を裏打ち材料としての厚さ120μmのポリ塩
化ビニルフィルムの片面に1図示してなるダイス16を
用いて、 200,4FBの厚みでラミネートすると共
に剥離フィルム22を仮着し、連続的にプラスターをl
1li造し丸。
This paste was laminated to a thickness of 200.4 FB on one side of a polyvinyl chloride film with a thickness of 120 μm as a backing material using a die 16 as shown in the figure, and a release film 22 was temporarily attached to it, and the film was continuously laminated. plaster
1li zoushimaru.

このプラスターは充分な感圧接着性を有し、単位体積当
りのサリチル酸モノグリコール含有量(測メントール含
有歇は4゜29%(理論配合量は4゜36%)であり、
薬物の損失は殆んどみらntいものである。
This plaster has sufficient pressure-sensitive adhesive properties, has a monoglycol salicylate content per unit volume (measured menthol content is 4°29% (theoretical content is 4°36%),
The loss of drug is almost negligible.

実施的3 2本合せたスクリーー外径5Qaa、バレル[す216
0m1.バレルとスクリー−との間隙1.001111
で、添付図面と略同−のゾーン配置とした二軸スクリー
ー押出磯(1旦し、■〜II=200℃、f=140℃
、IV=95℃、V=85℃%VI−80℃、■〜■=
85℃、速度勾fji!” 31400/m1n)を用
い、供給口2から、スチレン含有量14%、f均分子緻
125000のスチレンーイソプレンースチレ/ブロッ
ク#cte体を264゜5f?/minの割合で連続的
に供給し、以下供給口3から軟化点が100℃の脂環式
飽和炭化水素前置の噛溶融物を285゜7ノ/ rn 
i nで、供給口4から粘度55セイギルト秒のfi劾
パラフィンを248゜3 iP/ m 1 nとゾルビ
タンモノオレエート58.5ノ/rB i 、nとの割
合で、供給口δη為ら水を445.5iP/ m i 
lIC1供給口6からサリチル酸クリコール20部、l
−メントール3部、a/−力/ファー3部及びチモール
1部からなる混合薬物を58.2?/ m i nで連
続的に供給して均一に混合して、W/○型エマルジョン
系感圧接着性バッグ剤用膏体を製造した。
Practical 3 Combined scree outer diameter 5Qaa, barrel [S216
0m1. Gap between barrel and scree 1.001111
Then, a twin-screw extruded rock with a zone arrangement approximately the same as that shown in the attached drawings (1 time, ■ ~ II = 200 °C, f = 140 °C
, IV=95℃, V=85℃%VI-80℃, ■~■=
85℃, speed gradient fji! 31400/m1n), styrene-isoprene-styrene/block #cte body with a styrene content of 14% and an f-average molecular density of 125000 was continuously supplied from the supply port 2 at a rate of 264° 5f?/min. Then, from the supply port 3, the melted alicyclic saturated hydrocarbon having a softening point of 100°C was fed at 285°7/rn.
In the feed port 4, paraffin having a viscosity of 55 Seigilt seconds was added at a ratio of 248°3 iP/m 1 n and sorbitan monooleate 58.5 n/rB i ,n from the feed port δη. 445.5 iP/m i of water
20 parts of glycol salicylate from lIC1 supply port 6, l
- Mixed drug consisting of 3 parts of menthol, 3 parts of a/-force/fur and 1 part of thymol at 58.2? /min to produce a W/○ type emulsion pressure-sensitive adhesive bag material.

この膏体を長打ち材料としての坪量130ノ/、/のポ
リエステル系不織布の片面に、図示して々るダイス16
を用いて、700声風のIvみで塗布と共に剥離フィル
ムを貼り合せて室亀域で冷却し〔ゲル化させ、パップ剤
を連続的に製造した。
This paste was pressed onto one side of a polyester non-woven fabric with a basis weight of 130 mm and a die 16 as shown in the figure.
A cataplasm was continuously produced by applying the product using a 700-voice I.V. and attaching a release film to it, and cooling it in the room to gel it.

このバック剤は、充分な冷感と#&珊効里を有する感圧
接着タイプで、II′#!Jの損失は#I1表に示す通
りである。なお第1表中の参考含有値は、押出機の取り
出し口Aからナンプリングした膏体用組′ 酸物の薬物
緻を測定量したものである0第    1    表 
  (巣位 哩/P)実1ilii列4 2本合せた;くクリーーー外径50olI111 バレ
ル長さ2160mm、 /:L/A/とスクリ・ニーと
の間隙1.OQmmで、添付図面と略同−のゾーン配置
とした二軸スクリ^−理出磯(1旦し、■−40℃、ト
1=80℃、IV 〜IX=100C,速度勾配= 1
5700/man )を用い、供@LI2.・ノ・ら、
アクリル酸n−ブチル90部、メチル、ツタアクリレー
ト10部、2−ヒドロキシエチルアクリレート1.5部
及びア/ビスイノブチロニトリル0.2部部からなるア
クリル系共重合物を10(H’/n;+i:1で、供給
口5からジエチルセバケート:I−メチルアントラキノ
ン−50:1の分散液を10ノ/ m i nで、供給
口6からジエチルセパゲート:デイクロフエナツクナト
リエウム−9:1の分散液を20j’/minで夫々連
峨的((哄袷して均一に混合しC1医薬製剤用組唆混和
物を咋成し、これをダイス16を用いて、鴫打ち材料と
じCの厚さ80μmのポリエチレンフイルムヒに40p
s(Dliさで塗投し、この表面t2800Aの波長を
毎する400W高圧水銀ランプ(距@10cm)で3分
間紫外線照射して架爾させ、消炎性医薬製剤を連続的に
製造しto この該製剤は充分な皮’il接着性を有すると共にすぐ
7″L九経皮吸収性を示し、製造工程中における薬物の
損失は殆んどみらルなかった。
This backing agent is a pressure-sensitive adhesive type that has a sufficient cooling sensation and # & coral effect, and has II'#! The loss of J is as shown in Table #I1. Note that the reference content values in Table 1 are the measured amounts of the drug concentration of the acid compound for plaster sampled from the outlet A of the extruder.
(Position /P) Real 1ilii row 4 2 pieces combined; Scree outer diameter 50ol I111 Barrel length 2160mm, gap between /: L/A/ and Scree knee 1. OQmm, two-axis screen with zone arrangement approximately the same as the attached drawing.
5700/man), and provided @LI2.・No・ra、
10 (H'/ At a ratio of n; A 9:1 dispersion was mixed uniformly at 20j'/min to form a C1 pharmaceutical preparation compound, which was then mixed using a die 16 to form a powdered material. 40 pages on a polyethylene film with a thickness of 80 μm for binding C.
s (Dli) and irradiated with ultraviolet rays for 3 minutes using a 400 W high-pressure mercury lamp (distance @ 10 cm) with a wavelength of 2800 A on the surface to continuously produce an anti-inflammatory pharmaceutical preparation. The formulation had sufficient skin adhesion and was readily absorbable through the skin, with almost no drug loss during the manufacturing process.

上記趣施例からも明らかな如く、本発明の製法に工nば
、生理活性物質の損失を礪めC少なくして、任童の生理
活性物質含有物を提供できるものである。
As is clear from the above examples, by applying the production method of the present invention, it is possible to reduce the loss of the physiologically active substance and reduce the amount of C, thereby providing a physiologically active substance-containing product.

【図面の簡単な説明】[Brief explanation of the drawing]

図顕は本発明に用いる一軸スクリーー押出機の4/f出
碩人 日東lK気工業株式貧仕 代表者±6三部
The diagram shows the single-screw extruder used in the present invention, 4/f maker, Nitto lK Industrial Co., Ltd. representative, ± 6 three parts.

Claims (1)

【特許請求の範囲】 1)内容物を捩面更新しつつ連続的に移υiεで且つ上
記移184程の全域に亘る!@度例御磯構と膜数1−の
原料供給口とを端えた密閉系移送4を使用し、この移送
器内へ皮喚形成及び層m能を有する熱0工塑性高分子材
料を含む担体と生理活性物質とをL記供給口から連続供
給し、上記移送IM根の全域にM)で所定の@菫に加熱
制御しつつ上記担体と物質とを密閉状態で均一に混合し
て連続的に移送器から取り出すことを特徴とする生4活
性物質含有物の製法。 2)#閉基移送器が一軸又は二軸型のスクリーー押出機
である特許請求の範囲第1頃記峨の生tlttiうる原
材からなるものである特許請求の範囲第11貞dビ載の
生4活性物゛繊倉有物の製法。 %許清求の範囲第1及び第3項の各j’Lかに記載の生
理活性物質含有物の製法ワ 5)生理活性物質が薬4学的に許容される薬物であるf
Iif’F祷求の範囲第1項記載の生理活性物質よ角°
吻の製法。 6)薬物が消炎繍櫂剤である特許請求の範囲第5LJi
記賊の生4活注物質含有物の製法。
[Claims] 1) Continuously transfer the contents at υiε while updating the torsional surface, and over the entire area of the above transfer 184! A closed system transfer system 4 is used, which has a raw material supply port with a number of layers of 1-, and a thermoplastic polymeric material having the ability to form a skin and form a layer is contained in this transfer device. The carrier and the physiologically active substance are continuously supplied from the supply port indicated by L, and the carrier and the substance are uniformly mixed in a sealed state while controlling heating to a predetermined @ Violet with M) over the entire area of the transferred IM root. A method for producing a product containing four active substances, which is characterized in that the product is taken out from a transfer device automatically. 2) The closed group transfer device is a single-screw or twin-screw type scree extruder.Claim 1.The device is made of the raw material that can be used in the same way as described in Claim 1.Claim 11. The manufacturing method of 4 raw active substances "Sakura Yumono". 5) The manufacturing method of the physiologically active substance-containing product described in each of Items 1 and 3 above. 5) The physiologically active substance is a pharmaceutically acceptable drug.
Iif'F Required Range The angle of the physiologically active substance described in item 1
How to make the snout. 6) Claim 5LJi in which the drug is an anti-inflammatory drug
A method of manufacturing a substance containing the 4 life notes of a thief.
JP57073570A 1982-04-30 1982-04-30 Production of material containing physiologically active substance Granted JPS58189112A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57073570A JPS58189112A (en) 1982-04-30 1982-04-30 Production of material containing physiologically active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57073570A JPS58189112A (en) 1982-04-30 1982-04-30 Production of material containing physiologically active substance

Publications (2)

Publication Number Publication Date
JPS58189112A true JPS58189112A (en) 1983-11-04
JPH0530806B2 JPH0530806B2 (en) 1993-05-11

Family

ID=13522061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57073570A Granted JPS58189112A (en) 1982-04-30 1982-04-30 Production of material containing physiologically active substance

Country Status (1)

Country Link
JP (1) JPS58189112A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411739A (en) * 1987-09-01 1995-05-02 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the controlled delivery of nicotine, process for the production thereof and use thereof
WO2000019861A1 (en) * 1998-10-06 2000-04-13 Unilever Plc Process and apparatus for the production of a deodorant or antiperspirant composition
WO2001076409A1 (en) * 2000-04-05 2001-10-18 Unilever Plc Process for the production of a deodorant or antiperspirant product
CN101884595A (en) * 2010-07-26 2010-11-17 常州市泛亚电器制造有限公司 Skeleton type medical patch production line
CN101999987A (en) * 2009-12-22 2011-04-06 侯玉庆 Process for preparing externally-used patch
CN102178605A (en) * 2011-03-09 2011-09-14 天津大学 Traditional Chinese medicine cataplasma forming device with automatic detection function
CN104586633A (en) * 2014-12-23 2015-05-06 贵州景峰注射剂有限公司 Method for cooling medicine refining equipment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS578139A (en) * 1980-06-18 1982-01-16 Ikegai Corp Extruding method of thermoplastic material
JPS5741932A (en) * 1980-08-27 1982-03-09 Toshiba Mach Co Ltd Manufacture of extruded article and device therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS578139A (en) * 1980-06-18 1982-01-16 Ikegai Corp Extruding method of thermoplastic material
JPS5741932A (en) * 1980-08-27 1982-03-09 Toshiba Mach Co Ltd Manufacture of extruded article and device therefor

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411739A (en) * 1987-09-01 1995-05-02 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the controlled delivery of nicotine, process for the production thereof and use thereof
WO2000019861A1 (en) * 1998-10-06 2000-04-13 Unilever Plc Process and apparatus for the production of a deodorant or antiperspirant composition
WO2001076409A1 (en) * 2000-04-05 2001-10-18 Unilever Plc Process for the production of a deodorant or antiperspirant product
CN101999987A (en) * 2009-12-22 2011-04-06 侯玉庆 Process for preparing externally-used patch
CN101884595A (en) * 2010-07-26 2010-11-17 常州市泛亚电器制造有限公司 Skeleton type medical patch production line
CN102178605A (en) * 2011-03-09 2011-09-14 天津大学 Traditional Chinese medicine cataplasma forming device with automatic detection function
CN104586633A (en) * 2014-12-23 2015-05-06 贵州景峰注射剂有限公司 Method for cooling medicine refining equipment

Also Published As

Publication number Publication date
JPH0530806B2 (en) 1993-05-11

Similar Documents

Publication Publication Date Title
DE69433859T2 (en) Breathable, adhesive body for administering a drug to the skin
Goyanes et al. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems
EP0993828B1 (en) Method of producing coated solid dosage forms
DE3205258C2 (en)
EP0219762B1 (en) Process for the preparation of an administration and dosage for drugs, reagents or other active substances
EP0988106B1 (en) Method for producing small-particle preparations of biologically active substances
TW474824B (en) The production of solid pharmaceutical forms
DD159966A5 (en) METHOD FOR THE PRODUCTION OF MEDICAMENTS WITH RETARDANT ACTIVE RELEASE
CN100411651C (en) Medical gel and its preparing method and device
JPH03206110A (en) Release system for releasing activator gradually and production thereof
DE19710213A1 (en) Process for the manufacture of solid combination dosage forms
DE19603723A1 (en) Exothermic device and an adhesive pad using it
DE19753298A1 (en) Process for the preparation of solid dosage forms
CN101321511A (en) Topical film compositions for delivery of actives
DE19847618A1 (en) Production of solid dosage forms, used for e.g. pharmaceuticals or insecticides, by preparation of plastic mixture from polymeric binder and active agent under controlled conditions
DE1492107B2 (en) PROCESS FOR MANUFACTURING AN ACETYL SALICYLIC ACID TABLET
DE2419795C2 (en) Shaped body for delivering an active ingredient to an aqueous environment
CN102597149A (en) Process for the continuous manufacture of a polyisobutylene based transdermal patch
JPS58189112A (en) Production of material containing physiologically active substance
EP1158962A1 (en) Method for producing solid dosage forms containing cyclodextrin
CN1325298A (en) Method for producing solid dosing forms
CN101999987B (en) Process for preparing externally-used patch
Nasiri et al. 3D printing of bioactive materials for drug delivery applications
JPS6263512A (en) Base for hydrous gel patch
KR100427728B1 (en) New additive concentrate